The world's first fully autonomous, multi-tenant agentic AI platform for genetic testing, clinical diagnostics, pharmacogenomics, and precision medicine. 12 autonomous agents. Zero-hallucination clinical reports. HIPAA compliant.
12 autonomous AI agents working in real-time. Each agent is a domain expert — orchestrated, quality-gated, and self-correcting.
Routes genomic queries across the agent mesh. Manages state, parallelism, and quality gates.
ACMG/AMP 5-tier classification with proprietary VIS (Variant Intelligence Score) across 8 evidence streams.
CPIC Level A/B interpretation. 300+ drug-gene pairs. Metabolizer phenotype prediction.
TMB, MSI, gene fusions, OncoKB Level 1-4 therapy matching. Companion diagnostics.
6-dimensional quality scoring on every output. Groundedness, Accuracy, Reliability, Variance, Inference Cost, Safety.
Autonomous self-healing. Detects quality failures, rewrites outputs, max 3 iterations. Zero-hallucination guarantee.
Clinical-grade reports with every claim cited. Configurable templates per lab/institution. PDF/FHIR/HL7.
PubMed RAG synthesis. Real-time evidence retrieval with citation graphs and relevance scoring.
ChEMBL/AlphaFold drug target validation. ADMET prediction. Lead compound optimization.
Real-time NCT eligibility matching. Molecular profile to trial alignment across 400K+ active trials.
Automated VCF ingestion, normalization, annotation, and quality filtering. Multi-format support.
HIPAA middleware, PHI encryption, audit trails, role-based access, per-tenant KMS isolation.
7 curated knowledge bases powering evidence-grounded interpretation. Every clinical assertion is traceable.
Production-ready across 9 clinical specialties. Each domain has specialized agent configurations and validated interpretation pipelines.
Comprehensive germline cancer risk assessment with multi-gene panel interpretation and cascade testing guidance.
Inherited cardiac conditions including cardiomyopathies, channelopathies, and familial hypercholesterolemia.
WES/WGS analysis with trio support, RNA-Seq integration, and phenotype-driven variant prioritization.
CPIC Level A/B drug-gene interaction reporting with metabolizer phenotype prediction and prescribing guidance.
Tumor profiling with actionable therapy matching, biomarker quantification, and clinical trial eligibility.
NIPT interpretation, chromosomal microarray analysis, and newborn screening follow-up.
Genetic testing for epilepsy, intellectual disability, autism spectrum, and neurodegenerative conditions.
AI-powered target validation, ADMET prediction, and lead compound optimization using ChEMBL and AlphaFold.
Real-time molecular profile to NCT trial matching across 400K+ active studies worldwide.
Native connectors for the genomics and healthcare ecosystem. Deploy on day one.
Bidirectional FHIR R4 integration with major EHR and laboratory information management systems.
Direct VCF ingestion from all major sequencing platforms and bioinformatics pipelines.
Any-cloud deployment with Kubernetes orchestration. On-prem, hybrid, and sovereign cloud support.
Export genomic intelligence to your analytics stack. Real-time streaming and batch modes.
Production-grade, cloud-native, multi-tenant. Built for healthcare scale and regulatory compliance.
FastAPI backend with async agent mesh. Parallel execution, state management, and configurable quality gates.
Real-time genomic analysis dashboard with interactive variant browsers, quality metrics, and report generation.
PostgreSQL with row-level security for multi-tenancy. Redis caching. Kafka event streaming. Qdrant vector DB for RAG.
HIPAA-grade PHI encryption, 7-year audit retention, per-tenant KMS, SOC2 Type II in progress.
GenomixIQ is engineered from day one for strategic integration — whether scaling as a standalone product or positioning for acquisition by genomics leaders.
500+ tenant capacity with complete data isolation, per-tenant KMS encryption, and configurable agent pipelines per institution.
Patent-pending VIS Algorithm and Molecular Agent Mesh topology. G-ARVIS quality engine is a trade secret with no open-source equivalent.
Clinical genomics, DTC testing, pharma R&D, and precision medicine. GenomixIQ addresses the fastest-growing AI segment in life sciences.
Not a single-use tool. GenomixIQ serves hereditary cancer, cardiology, rare disease, PGx, somatic oncology, prenatal, neuro, drug discovery, and clinical trials.
Compliance is built in, not bolted on. End-to-end encryption, audit logging, BAA-ready infrastructure, FDA 21 CFR Part 11 roadmap.
12 specialized agents, 7 curated knowledge bases, zero-hallucination clinical reports, and a self-correcting quality engine. Performance compounds with scale.
Walk through a live simulation of variant analysis, agent orchestration, clinical report generation, and quality scoring. No signup required.
Launch Interactive Demo